12-Apr-2024 | BC | GLOBAL HEALTH LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.
Details are as under:
Details
Reason Of Change | 30-Apr-2024 | |
28-Mar-2024 | BC | Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Monday | 01-Apr-2024 | |
21-Mar-2024 | BC | The Board in its meeting held today, has approved the scheme of Amalgamation between the Company and Medanta Holdings Private Limited, wholly-owned subsidiary of the Company.
The Board at its meet | 21-Mar-2024 | |
01-Mar-2024 | BC | Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Saturd | 02-Mar-2024 | |
30-Jan-2024 | BC | Global Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2024 inter alia to consider and approve the Unaudited Financial Results (both standal | 08-Feb-2024 | |
No Dividends has been declared by MEDANTA
No Bonus has been declared by MEDANTA
No Split has been declared by MEDANTA
RightsNo Rights has been declared by MEDANTA
Book Closure
30-Apr-2024 | - | GLOBAL HEALTH LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.
Details are as under:
Details
Reason Of Change |
01-Apr-2024 | - | Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Monday |
21-Mar-2024 | - | The Board in its meeting held today, has approved the scheme of Amalgamation between the Company and Medanta Holdings Private Limited, wholly-owned subsidiary of the Company.
The Board at its meet |
02-Mar-2024 | - | Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Saturd |
08-Feb-2024 | - | Global Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2024 inter alia to consider and approve the Unaudited Financial Results (both standal |